Skip to main content
OpenTrials
Completed

NCT Number: NCT03500536

Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.

The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Positive screen on PHQ-9

Exclusion criteria

  • Does not own or use a mobile smart phone

Treatment and study plan

IntelliCare

Behavioral

A suite of mobile apps that use principles of computerized therapy to decrease symptoms of depression.

Primary outcomes

  1. Symptoms of depression

    Time frame: 8 weeks

    Using the PHQ-9 screener

Sponsors and collaborators

Lead sponsor

Actualize Therapy

Industry

Collaborators

  • University of Arkansas

Registry information

Official study title

Implementing an Innovative Suite of Mobile Applications for Depression and Anxiety

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Apr 18, 2018
Registry last updated
Apr 30, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.